Related Experiment Video
Updated: Aug 13, 2026
09:54
Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
Therapeutic antibody production technologies: molecules, applications, expression and purification
1Celitech-Chiroscience Ltd, 216 Bath Road, Slough, Berkshire SL1 4EN, UK. dhumphre@celitech.co.uk
Current Opinion in Drug Discovery & Development
|May 31, 2001
Summary
Selecting antibody therapeutics requires comparing engineered formats and production methods for optimal efficacy. Intellectual property considerations also influence the choice of new therapeutic entities.
Area of Science:
- Biotechnology
- Immunology
- Drug Development
Background:
- Antibody-based therapeutics are increasingly utilized across diverse medical fields.
- Numerous engineered antibody formats and methods for generating specific binding are available.
- Evaluating these options is essential for therapeutic development.
Purpose of the Study:
- To compare the function and efficacy of various engineered antibody formats.
- To assess different methods for antibody production and specificity tailoring.
- To inform the selection process for new antibody-based therapeutic entities.
Main Methods:
- Review of engineered antibody formats.
- Analysis of antibody production methodologies.
- Comparative assessment of antibody efficacy and function.
Main Results:
- Diverse antibody formats and production methods exist, each with unique characteristics.
- Functionality and efficacy vary significantly across different engineered antibodies.
- Intellectual property landscape presents additional considerations for selection.
Conclusions:
- Informed selection of antibody therapeutics necessitates a comprehensive comparison of molecular formats and production strategies.
- Efficacy, function, and intellectual property are key factors in choosing a therapeutic antibody.
Related Concept Videos
01:31Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...